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The effect of L-tryptophan on the heart in
rabbits via chronic hypoxia
Figen NARİN1, Nazmi NARİN2, Fatmagül BAŞARSLAN1, Ali BAYKAN2,
Sadettin SEZER2, Hülya AKGÜN3, Aynur AKIN4, Mustafa AKÇAKUŞ2, Hakan CEYRAN5

Aim: To evaluate the protective effect of tryptophan on an experimentally produced hypoxic myocardial injury via
biochemical and pathological parameters.
Materials and methods: A total of 26 rabbits were divided into 3 groups. Group 1 (n = 9) was only exposed to hypoxia.
Group 2 (n = 10) was exposed to hypoxia and received L-tryptophan (200 mg/kg per day, orally for 5 days). Group 3 (n
= 7) was the control group.
Before the hypoxic injury and after the delivery of the medication, serum samples were taken for troponin-I, creatine
kinase myocardial isoenzymes (CK-MB), lactate dehydrogenase (LDH), glutathione peroxidase (GSH-Px), superoxide
dismutase (SOD), malondialdehyde (MDA), and nitric oxide (NO) analysis, and then the rabbits were sacrificed. Next,
the myocardium samples were taken and the myocardial NO, MDA, SOD, and GSH-Px enzyme activity levels were
studied histopathologically.
Results: In group 1, Serum GSH-Px and SOD activities were decreased. Conversely, troponin-I, CK-MB, and LDH were
elevated. Severe cardiac injury was observed histopathologically. In group 2, serum troponin-I and SOD values were
increased. Mild cardiac injury was demonstrated histopathologically.
When groups 1 and 2 were compared, tissue NO and MDA levels in group 1 were higher compared to group 2, but GSHPx level was found decreased in group 1.
Conclusion: Our findings support that there is a clear effect of the free oxygen radicals and the lipid peroxidation
products on hypoxic cardiac injury. In addition, L-tryptophan supplementation has a strong protective effect on hypoxic
heart by antioxidant activity.
Key words: Hypoxia, myocardial injury, cardioprotection, tryptophan, oxidative stress

Kronik hipoksili tavşanlarda L-triptofanın kalp üzerine etkisi
Amaç: Bu çalışmanın amacı, deneysel olarak meydana getirilmiş hipoksik miyokardial hasara karşı triptofanın koruyucu
etkisini, biyokimyasal ve patolojik parametreler kullanarak değerlendirmektir.
Yöntem ve gereç: Toplam 26 tavşan üç gruba ayrıldı. Grup 1, 9 tavşan yalnızca hipoksiye maruz kaldı. Grup 2, 10 tavşan
hem hipoksiye maruz kaldı ve L-triptofan aldı. Grup 3, 7 tavşan kontrol grubu olarak seçildi.
Hipoksik hasar öncesi ve ilaç tedavisi uygulandıktan sonra troponin-I, kreatin kinaz miyokard izoenzimi (CKMB), laktat
dehidrogenaz (LDH), glutatyon peroksidaz (GSH-Px), süperoksid dismutaz (SOD), malondialdehid (MDA) ve nitrik
oksit (NO) için analizler yapıldı ve tavşanlar sakrifiye edildi. Daha sonra miyokardiyal numuneler alındı ve NO, MDA,
SOD, GSH-Px enzim aktivite düzeyleri histopatolojik olarak değerlendirildi.
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Bulgular: Grup 1’de serum GSH-Px ve SOD aktivitesi azaldı. Aksine, troponin-I, CK-MB ve LDH arttı. Histopatolojik
olarak şiddetli kardiyak hasar gözlendi. Grup 2’de serum troponin-I ve SOD değerleri arttı. Histopatolojik olarak hafif
kardiyomiyopati gösterildi.
Sonuç: Bulgularımız, hipoksik bir kardiyomiyopatide serbest oksijen radikallerinin ve lipit peroksidasyon ürünlerinin
belirgin bir etkisi olduğunu desteklemektedir. Aynı zamanda, L-triptofan ilavesi, hipoksik kalp üzerine antioksidan bir
etki yaparak güçlü bir koruyucu etkiye sahiptir.
Anahtar sözcükler: Hipoksi, miyokardiyal hasar, kalbin korunması, triptofan, oksidatif stres

Introduction
Chronic hypoxia is associated with increased
oxidative stress as evidenced by marked lipid
peroxidation and induction of antioxidant enzyme
response in various tissue organs (1). Especially,
hypoxia and ischemia have an important role on
cardiovascular diseases (2). There are studies on
etiopathogenesis and prophylaxis of hypoxic and
ischemic injuries. By demonstration of the role of free
oxygen radicals and antioxidant enzymes in injury,
antioxidant treatment modalities are favorable in
these days (3).
In the early stages of myocardial ischemia/hypoxia,
neutrophils and monocytes infiltrate intima and
degenerate the endothelial cells. Free oxygen radicals,
cytokine, and nitric oxide are released by the
degeneration of the endothelial cells and cause lipid
peroxidation. The products of lipid peroxidation, such
as malondialdehyde (MDA), result in myocardial
damage (4,5).
Creatine kinase (CK-MB), lactate dehydrogenase,
and troponin-I (Tn-I) are used to determine the
myocardial injury (1). Researchers are still looking for
appropriate antioxidant agent to protect myocardium
from the hypoxic and ischemic injuries (3).
L-tryptophan is the precursor of melatonin and
has a protective effect on the free oxygen radical
neutralization (6). Reiter et al. reported that Nacetylserotonin, which is a derivative of melatonin or
tryptophan, also has a free oxygen radical
neutralization activity. Moosmann et al. reported that
membrane lipoproteins, especially in the lipid dense
regions, have high concentrations of tryptophan (7,8).
High levels of tryptophan protect the lipid layer from
peroxidation, which indicates that tryptophan may be
used as a pharmacological agent as a cytoprotective
antioxidant (9). Today, all the effects of tryptophan are
not clear yet, and in the literature there are a limited
number of studies on this subject.
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In this study, a myocardial hypoxic injury was
created experimentally and the protective effect of
tryptophan was evaluated by observing troponin-I
and CK-MB levels. Because they are involved in tissue
injuries, SOD, NO, GPX, MPO, and tryptophan
interactions were also evaluated.
Materials and methods
The study was performed on 26 New-Zealand
white rabbits weighing between 1300 g and 2600 g.
All rabbits were male with an age range of 60-90 days.
After a 15-day adaptation period, rabbits were
distributed into 3 groups: group 1(n = 9) was only
exposed to hypoxia. Group 2 (n = 10) was exposed to
hypoxia and received L-tryptophan. Group 3 (n = 7)
was the control group and received distillated water.
A hypoxic condition was obtained using a 25 × 25
3
× 62 cm funnel with input and output ports for air.
The funnel was ventilated with 10% oxygen and 90%
nitrogen mixture at 5 L/min flow rate for 5 min.
Oxygen-nitrogen mixture flow continued for an
additional 10 min after the rabbits were placed in the
funnel. The oxygen saturation and the heart rate were
monitored with a pulse oximeter. The rabbits were let
to breathe room air for 10 min (1,10). During this
process, when bradycardia or respiratory failure had
developed, the experiment was discontinued.
Hypoxia and tryptophan application: Same
hypoxic condition was applied to the rabbits in group
2 for only 5 min-ventilation. Then, L-tryptophan
(Sigma Chemical Company, Sigma, St. Louis. MO)
was administered orally in the amount of 200mg/kg
per day for 5 days.
After the adaptation period, serum samples were
taken from groups 1 and 2 at the beginning of the
study (day 0) and day 6 after the hypoxia for troponinI, CK-MB, LDH, plasma GSH-Px, SOD, MDA, and
NO. At the end of day 6, animals were sacrificed and
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histopathologic analyses were performed. In addition,
cardiac tissue samples were taken to be analyzed.
Frozen serum samples were dissolved and CK-MB
and Tn-I levels were analyzed on the same day. Serum
CK-MB (with 0.5 cc serum samples) analyses were
performed using a Konelab 60i auto analyzer
(Thermofisher Scientific, Finland) with the reagent
kits produced by Medkim corp. Serum Tn-I levels
were studied using an Innotrac Aio Immunoanalyzer
(Innotrac diagnostics, Turku, Finland) with Innotrac
Aio TM Troponin I Analyte Pen kit (with 0.5 cc serum
samples). Serum LDH levels were also studied using a
Konelab auto analyzer with LDH reagent kits
produced by Medkim in 0.5 cc serum samples.
Serum and myocardial GSH-Px activity
determination: The activity was calculated using
Paglia and Valentine’s combined enzymatic method:
measuring the peroxidation rate of H2O2 and
glutathion (GSH) reaction (11). Tissue GSH-Px
activity detection: myocardial homogenate
centrifuged at (1/4 w/v) 13200 rpm for 30 min and
obtained supernatant tamponated with a phosphate
tampon (0.05 M, pH = 7.4) and diluted (1/10). For
tissue GSH-Px activity detection, 0.05 mL sample was
used (11).
Serum and myocardial SOD activity levels were
measured by a method developed by Sun et al. (12).
Xanthine oxidase was used for superoxide producer
and inhibition of nitroblue tetrazolium (NBT)
reduction. Tissue SOD of activity measurement: 0.05
mL supernatant obtained from myocardial
homogenate was diluted (1/10) with phosphate
tampon (pH: 7.4).
Detection of Serum MDA activity: Jain’s method
was used: measurement of colorful product of MDA
and thiobarbituric acid (TBA) at 532 nm wavelength
(12). Tissue MDA detection was performed using a
methods developed by Okawa et al. (14).
Tissue NO detection: The 0.05 mL homogenate
obtained from the supernatant was diluted (1/4 v/v)
by Somogy reactant (10% ZnSO4 and 0.5 N NaOH)
and then deproteinized and centrifuged at 1500 rpm
for 10 min at + 4°C (15). Using this supernatant, NO
(NO2 + NO3) levels were measured. The nitrate (NO3)
first reduced to nitrite (NO2) and the standard scale
for nitrite was used to determining the nitrate levels
(16).

To histopathological evaluation of the hematoxylin
and eosin stained slides were performed using a light
microscope. The scoring was achieved by the severity
of the histopathological changes (17).
The severity of the cardiac injury degree was
graded between zero and 3 as shown below.
0: no evident cardiac injury, 1: mild cardiac injury,
2: moderate cardiac injury, 3: severe cardiac injury.
Statistical Analysis
SPSS 10.0 was used for statistical analysis. Median
(minimum-maximum) values were used for
comparing the parameters. For comparing the groups,
Kruskal-Wallis variance analysis and Mann-Whitney
U tests were used; comparisons within the groups
were carried out by Wilcoxon signed ranks test.
Statistical significance was set at a level of P < 0.05.
Results
In group 1, significant increase in troponin-I, CKMB, LDH, SOD, and a decrease in GSH-Px were
detected on day 6 as shown in Table 1 (P < 0.05).
Severe
cardiac
injury
was
observed
histopathologically. GSH-Px and SOD activity in this
group was also found decreased (Table 1).
In group 2, troponin-I and SOD activity increased
significantly as shown in Table 2. (P < 0.05). However,
increase in troponin-I was less pronounced as
compared to group 1. There was no significant change
in other parameters as presented in Table 2 (P > 0.05).
NO levels in groups 1 and 2 were statistically much
higher than the control group (P < 0.05). In group 2,
NO level was significantly lower than group 1 as
shown in Table 3 (P < 0.05). When the tissue SOD
levels were compared, all groups were very similar (P
> 0.05). In group 1, the tissue MDA level was
statistically much higher compared to groups 2 and 3
(P < 0.05), and also group 2 MDA level was
statistically much higher compared to group 3 (P <
0.05, Table 3). GSH-Px level in group 2 was higher
compared to group 1 (P < 0.05, Table 3).
When the histopathological findings were
compared, the score of group 1 statistically much
higher compared to the other groups as shown in
Table 4 (P < 0.05).
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Table 1. Serum CKMB, LDH and Tn-I, plasma MDA, SOD, GSH-Px and NO levels in group 1 median (min-max).
n=9

Day 0

Day 6

P

Tn-I (ng/mL)

0.21(0.16-0.25)

0.32(0.22-0.41)

<0.05

CK-MB (U/I)

3857(939-8447)

5450(1288-7781)

<0.05

660(603-984)

1276(765-8700)

<0.05

LDH (IU)
MDA (μmol/L)

0.360(0.288-1.232)

0.616(0.384-1.648)

>0.05

SOD (U/L)

1.023(0.929-1.411)

0.882(0.770-0.964)

<0.05

GSH-PX (U/mL)

0.224(0.127-0.488)

0.122(0.096-0.154)

<0.05

6.04(1.64-8.56)

7.52(0.00-10.50)

>0.05

NO (μmol/L)

Table 2. Serum CKMB, LDH and Tn-I, plasma MDA, SOD, GSH-Px and NO levels in group 2 median (min-max).
n=9

Day 0

Day 6

P

Tn-I (ng/mL)

0.21(0.19-0,32)

0.25(0.20-0.47)

<0.05

CK-MB (U/I)

3569(1596-5250)

4285 (2518-6219)

>0.05

702(288-2570)

689(388-1498)

>0.05

LDH (IU)
MDA (μmol/L)

0.392(0.272-1.152)

0.447(0.352-1.088)

>0.05

SOD (U/L)

0.999(0.729-1.294)

1.440(0.858-1.635)

<0.05

GSH-PX (U/mL)

0.128(0.104-0.635)

0.130(0.084-0.824)

>0.05

7.36(7.10-9.44)

>0.05

NO (μmol/L)

6.80(3.04-11.72)

Table 3. Comparison of tissue GSH-Px, NO, SOD, and MDA levels.

Group

n

GSH-Px
(mU/μg protein)
Median (Min-Max)

NO
(μmol × 10-3/μg protein)
Median (Min-Max)

SOD
(U/μg protein)
Median (Min-Max)

MDA
(nmol/μg protein)
Median (Min-Max)

1
2
3

9
10
7

0.0039(0.0023-0.0043)
0.0054(0.0022-0.0083)b
0.0046(0.022-0.0055)

0.10 (0.05-0.15)a
0.087 (0.04-0.18)a,b
0.035 (0.017-0.077)

4.96(2.68-6.96)
6.09(1.39-11.28)
4.97(1.33-7.26)

0.16(0.10-0.45)a
0.09(0.02-0.27)a,b
0.031(0.007-0.12)

a
b

P < 0.05, when compared with group 3
P < 0.05, when compared with group 1

Table 4. Comparison of histopathological cardiac injury scores.
Cardiomyopathy scores
Group

1
2
3
a

Hypoxic
Hypoxic + L-Tryptophan
Control

P < 0.05, when compared with group 3
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n

9
10
7

Mild (%)

Moderate (%)

Severe (%)

0
40
0

33
20
0

66a
40
0
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Discussion
Cardiovascular diseases, especially in the
developed countries, are the main cause of morbidity
and mortality in the world. Early detection of hypoxia
and ischemia, the main etiology of cardiovascular
diseases, and early and appropriate treatment should
be prevent mortality (4).
L-tryptophan should have similar effects like
melatonin because it is the precursor amino acid of
melatonin. There are few studies on the antioxidant
activity of L-tryptophan: the way of action is
preventing superoxide anion and hydrogen peroxide
production. Therefore, it may be used as an
antioxidant agent (18,19).
Jaffe et al. reported that Tn-I is more sensitive and
specific than CK-MB in the myocardial injury (20).
LDH isoenzyme activities are not specific for
myocardial injury. CK-MB sensitivity is 92%, and TnI sensitivity is over 93% after the first few hours.
Vordenwinkler et al. reported that cardiac Tn-I
increased in parallel to cardiac Tn-T, CK-MB, and
LDH in effluents from an isolated perfused rat hearts
after hypoxia-reoxygenation-induced myocardial
injury (21).
In this study, Tn-I, CKMB, and LDH levels in the
hypoxic group were found significantly elevated,
which is in agreement with the literature. Tn-I, CKMB, and LDH level elevations demonstrate that
significant hypoxia caused a myocardial injury. In the
hypoxic group that received tryptophan, although
mild Tn-I elevation was observed, there was no
significant change in CK-MB and LDH. Therefore,
this should signify that the tryptophan medication
controlled the myocardial injury, and in minor
injuries Tn-I is more reliable than CK-MB and LDH
because of the minor changes in CK-MB and LDH
levels. These results were also supported by the
histopathologic findings.
A production of the free oxygen radicals, a lipid
peroxidation and a decrease in the antioxidant
enzymes are the major factors in the pathogenesis of
a hypoxic myocardial injury (3). In the case of the
myocardial ischemia reperfusion, Ferrari et al.
advocated that the degree of an injury depended on
the amount of the free oxygen radicals and the
antioxidant defense systems (22). A study by Prasad et

al. showed that an increase in MDA was detected (23).
Therefore, he concluded that in the ischemic
conditions, an elevation in free oxygen radicals results
in an inhibition or a decrease of the antioxidant
defense system.
In our study, there was a statistically significant
decrease in MDA in the tryptophan group than the
hypoxic group, and we found the same results in the
tissue. These results indicated that the antioxidant
activity of tryptophan was from the inhibition of the
lipid peroxidation.
Depre et al. concluded that there is an increase in
the NO synthase activity after the myocardial
ischemia of a rabbit heart (24). This increase causes
the NO deposition and myocardial damage.
In our study, NO levels in tissues of the hypoxic
group were significantly higher compared to the other
groups. High NO levels in the hypoxic group
supported that NO had an effect on the hypoxic
myocardial injury. The myocardial NO levels in the
tryptophan group were lower than the hypoxic group.
These results showed that myocardium was protected
by tryptophan.
The antioxidant enzymes, which protects the
cardiomyocytes from the oxygen radicals, are GSHP and SOD. Guarnieri et al. reported that there was a
decrease in the GSH-Px and SOD activity in the
myocardial hypoxemia/ischemia (2,25). Kihlström et
al. and Hoshida et al. showed that, after 5 min
ischemia, mitochondrial SOD, catalase, and GSH-Px
activity increased in a dog heart (26,27).
In our study, the plasma GSH-Px and SOD level
decreased significantly in the hypoxic group. In the Ltryptophan group, there was a statistically significant
increase in SOD, but the increase in GSH-Px activity
was not significant this group. In the tissue we found
that GSH-Px activity in L-tryptophan was higher than
hypoxemic group and this increase was statistically
significant. SOD activity in the tissue did not change
significantly. These results showed that the
antioxidant activity in hypoxic injury was increased
by tryptophan.
In our study, there were severe myocardial damage
findings, such as a myocardial fibril swelling,
interstitial edema, disorganization, and a necrosis in
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the hypoxic group. In the group that received Ltryptophan, we found mild to moderate
cardiomyopathy findings, such as a normal
myocardium accompanied to a myocardial fibril
swelling, interstitial edema, and disorganization. It
was observed that L-tryptophan did not protect the
heart injury completely, but regressed the hypoxia
effects. Our histopathological findings supported that
L-tryptophan as an antioxidant could regress the
myocardial injury. Our findings were in agreement
with Yuan and Llesuy (28,29).

This study showed that L-tryptophan has strong
antioxidant activity on hypoxic myocardial injury.
Further studies must be carried out on this subject to
improve our knowledge.
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